Abstract
ObjectiveTo estimate the proportion of cases of Crohn’s disease (CD) and ulcerative colitis (UC) that could be prevented by modifiable lifestyle factors.DesignIn a prospective cohort study of US adults from the Nurses’ Health Study (NHS; n=72 290), NHSII (n=93 909) and Health Professionals Follow-up Study (HPFS; n=41 871), we created modifiable risk scores (MRS; 0–6) for CD and UC based on established lifestyle risk factors, and healthy lifestyle scores (HLS; 0–9) derived from American healthy lifestyle recommendations. We calculated the population attributable risk by comparing the incidence of CD and UC between low-risk (CD-MRS≤1, UC-MRS≤2, HLS≥7) and high-risk groups. We externally validated our findings in three European cohorts: the Swedish Mammography Cohort (n=37 275), Cohort of Swedish Men (n=40 810) and European Prospective Investigation into Cancer and Nutrition (n=404 144).ResultsOver 5 117 021 person-years of follow-up (NHS, HPFS: 1986–2016; NHSII: 1991–2017), we documented 346 CD and 456 UC cases. Adherence to a low MRS could have prevented 42.9% (95% CI 12.2% to 66.1%) of CD and 44.4% (95% CI 9.0% to 69.8%) of UC cases. Similarly, adherence to a healthy lifestyle could have prevented 61.1% (95% CI 16.8% to 84.9%) of CD and 42.2% (95% CI 1.7% to 70.9%) of UC cases. In our validation cohorts, adherence to a low MRS and healthy lifestyle could have, respectively, prevented 43.9%–51.2% and 48.8%–60.4% of CD cases and 20.6%–27.8% and 46.8%–56.3% of UC cases.ConclusionsAcross six US and European cohorts, a substantial burden of inflammatory bowel diseases risk may be preventable through lifestyle modification.
Funder
National Research Council
Dutch Ministry of Public Health, Welfare and Sports
National Institutes of Health
the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
NIH
Crohn’s and Colitis Foundation
NHS
German Institute of Human Nutrition Potsdam-Rehbruecke
Swedish Cancer Society, Swedish Research Council
Catalan Institute of Oncology
Medical Research Council
Cancer Research UK
World Cancer Research Fund (WCRF), Statistics Netherlands
LK Research
Instituto de Salud Carlos III
Federal Ministry of Education and Research (BMBF)
Associazione Italiana per la Ricerca sul Cancro
Compagnia di SanPaolo
UM1
Ligue Contre le Cancer, Institut Gustave Roussy
Danish Cancer Society
German Cancer Research Center
NIHR Imperial Biomedical Research Centre
International Agency for Research on Cancer
Institut National de la Santé et de la Recherche Médicale (INSERM)